One Scan Only, Chest Screening Solution

AVIEW LCS B3

Demo Request
RSNA Virtual Booth

AVIEW LCS B3

Youtube
Brochure

 A medical imaging software that provides automated lung nodule detection and segmentation and its analysis from the Low-Dose CT chest images.

The Coreline LCS program has been the sole official solution selected from the ‘K-LUCAS’ (Korean Lung Cancer Screening) from its pilot project period of the YR 2017-2018, and its full-out screening from the YR 2019 till now.

Since 2019, with its full-out screening program, Coreline has been working with more than 300 hospitals (50 of which is connected to the ‘National Cloud’ with the Central Data repository system).

Big 3, (=frequently referred to as B3 Thoracic diseases) includes:

  • Lung cancer
  • COPD (Chronic Obstructive Pulmonary Disease)
  • CAC (Coronary Artery Calcification)

Features

Nodule AI CAD (KFDA Approved)

Computer-Aided Detection (CAD) for lung nodules
Zero waiting time by APS (Auto Processing Server)

Follow-up Mode

Current/ Previous study comparison by non-rigid registration
Nodule change information over time for all nodule types

Lung RADS | Brock Score

Lung-RADS (Ver. 1.0 or 1.1)
Brock Score (aka, PANCAN Risk Model)

EUPS & VDT

Volume Doubling Time Calculation
EUPS(European Position Statement)

GSPS & DICOM SR

Seamless & Easy Integration
Compatible with various PACS

‘In-depth’ Access

Editing & Detailed Nodule Information out of PAC VIEWER
when user want to access it

Products

AVIEW LCS™ B3

Youtube
Brochure

AVIEW COPD™

Youtube
Brochure

AVIEW CAC™

Youtube
Brochure

AVIEW Modeler™

Youtube
Brochure

Demo Request

Our team will contact you soon.

    Personal Contact

    Sean LeeCBO
    sean.lee@corelinesoft.com
    Alice KimOverseas Manager
    alice@corelinesoft.com
    John KimOverseas Manager (3D Printing)
    john@corelinesoft.com

    About Coreline

    We develop AI-based imaging diagnosis package, specializing in lungs. This includes lung cancer screening(LCS), COPD quantification, and coronary artery calcification (CAC) systems, we call it B3 systems, covering the 3 big diseases in thoracic imaging. More in-depth lung diagnosis products with analysis such as texture analysis for ILD/IPF and pneumonia detection including COVID-19 are soon to be expected.

    • The Official solution provider for the nationwide lung cancer screening program in Korea (K-LUCAS) from 2017, which is the 2nd state-level-reimbursed LCS program following the US from 2015
    • The Official solution provider of 4-ITLR project by the Nelson Team (Erasmus MC and iDNA in the Netherlands), which is a large early detection LCS Trial-based on B3 system. Two hospitals in Germany, DKFZ Heidelberg and Univ Hosp of Essen, are the members of this trial and our systems will be implemented in these hospitals from 2021.
    • Imminent Official solution provider for the German Trial by multi-university hospitals which is a pilot project to prove a national support necessary for LCS in Germany.
    • Our COPD systems are used by European customers such as NZ Leuven Belgium, Leicester Univ UK, Parma Univ Italy obtaining the appraisal as the best of breed for early detection, phenotyping, surgery support, and etc.